You just read:

GLATECT™ Is Now Covered by the Provincial Drug Plan in British Columbia for the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

News provided by

Pharmascience Inc.

Dec 07, 2018, 08:00 ET